Cite

HARVARD Citation

    von Roemeling, C. et al. (n.d.). EXTH-93. THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA. Neuro-oncology. p. vii231. [Online]. 
  
Back to record